[SYRE] YoY Quarter Result on 30-Sep-2018 [#Q3]

Stock
[SYRE] Spyre Therapeutics, Inc.
Announcement Date
30-Sep-2018
Financial Year
2018
Quarter
30-Sep-2018 [#Q3]
Profit Trend
QoQ- -26.59%
YoY- -51.35%
Quarter Report
SYRE's Result
SYRE's Financial Summary
View:
Show?
Quarter Result
30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 CAGR
Revenue 1,399 0 0 0 1,261 1,149 1,073 4.51%
PBT -20,281 -18,033 -21,573 -11,917 -7,874 -6,238 -3,413 34.54%
Tax 26 0 0 0 0 0 0 -
NP -20,307 -18,033 -21,573 -11,917 -7,874 -6,238 -3,413 34.57%
Tax Rate - - - - - - - -
Total Cost 21,706 18,033 21,573 11,917 9,135 7,387 4,486 30.02%
Ratio Analysis
30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 CAGR
NP Margin -1,451.54 0.00 0.00 0.00 -624.43 -542.91 -318.08 28.76%
Per Share
30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 CAGR
EPS -7.72 -7.24 -16.40 -13.55 -12.00 -11.70 -12.51 -7.72%
EPS Diluted -7.72 -7.24 -16.40 -13.55 -12.00 -11.70 -12.51 -7.72%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.